{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:43:20Z","timestamp":1765961000139},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10787-017-0386-4","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T13:43:15Z","timestamp":1502977395000},"page":"375-384","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The effects of \u03b2-d-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte\/macrophage, J774 cell line"],"prefix":"10.1007","volume":"26","clinical-trial-number":[{"clinical-trial-number":"irct2013062213739n1","registry":"10.18810\/irct"}],"author":[{"given":"Fahimeh","family":"Jafarnezhad-Ansariha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mir Saeed","family":"Yekaninejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad-reza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Vojdanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Javad","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Naser","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd H. A.","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Mirshafiey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"issue":"9894","key":"386_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron J, Bombardier C, Cannon C, Farkouh M, FitzGerald G (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (London, England) 382(9894):769\u2013779","journal-title":"Lancet (London, England)"},{"issue":"6","key":"386_CR2","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","volume":"104","author":"I Bjarnason","year":"1993","unstructured":"Bjarnason I, Hayllar J, Macpherson AJ, Russell A (1993) Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104(6):1832\u20131847","journal-title":"Gastroenterology"},{"issue":"21","key":"386_CR3","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","volume":"343","author":"C Bombardier","year":"2000","unstructured":"Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343(21):1520\u20131528 (1522 p following 1528)","journal-title":"N Engl J Med"},{"issue":"7","key":"386_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.CNE.0000413300.35194.01","volume":"34","author":"G Broc","year":"2012","unstructured":"Broc G, Vargas A (2012) Ankylosing spondylitis: review of pathogenesis, clinical features, neurologic complications, and treatment. Contemp Neurosurg 34(7):1\u20135","journal-title":"Contemp Neurosurg"},{"issue":"25","key":"386_CR5","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa003199","volume":"345","author":"F Catella-Lawson","year":"2001","unstructured":"Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345(25):1809\u20131817","journal-title":"N Engl J Med"},{"issue":"1","key":"386_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/rheumatology\/ket323","volume":"53","author":"F Ciccia","year":"2013","unstructured":"Ciccia F, Alessandro R, Rizzo A, Accardo-Palumbo A, Raimondo S, Raiata F, Guggino G, Giardina A, De Leo G, Sireci G (2013) Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis. Rheumatology 53(1):104\u2013113","journal-title":"Rheumatology"},{"issue":"1","key":"386_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","volume":"57","author":"RA Colbert","year":"2014","unstructured":"Colbert RA, Tran TM, Layh-Schmitt G (2014) HLA-B27 misfolding and ankylosing spondylitis. Mol Immunol 57(1):44\u201351","journal-title":"Mol Immunol"},{"issue":"1","key":"386_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/1529-0131(199801)41:1<180::AID-ART24>3.0.CO;2-V","volume":"41","author":"G Cunnane","year":"1998","unstructured":"Cunnane G, Bresnihan B, FitzGerald O (1998) Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis. Arthritis Rheumatol 41(1):180\u2013182","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"386_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3109\/08923973.2015.1113296","volume":"37","author":"MJ Fattahi","year":"2015","unstructured":"Fattahi MJ, Abdollahi M, Agha Mohammadi A, Rastkari N, Khorasani R, Ahmadi H, Tofighi Zavareh F, Sedaghat R, Tabrizian N, Mirshafiey A (2015) Preclinical assessment of beta-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug. Immunopharmacol Immunotoxicol 37(6):535\u2013540","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"11","key":"386_CR10","first-page":"780","volume":"42","author":"V Golder","year":"2013","unstructured":"Golder V, Schachna L (2013) Ankylosing spondylitis: an update. Aust Fam Phys 42(11):780\u2013784","journal-title":"Aust Fam Phys"},{"issue":"9149","key":"386_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","volume":"353","author":"C Hawkey","year":"1999","unstructured":"Hawkey C (1999) COX-2 inhibitors. Lancet 353(9149):307\u2013314","journal-title":"Lancet"},{"key":"386_CR12","doi-asserted-by":"publisher","first-page":"CD010952","DOI":"10.1002\/14651858.CD010952","volume":"7","author":"FP Kroon","year":"2015","unstructured":"Kroon FP, van der Burg LR, Ramiro S, Landew\u00e9 R, Buchbinder R, Falzon L, van der Heijde D (2015) Non\u2010steroidal anti\u2010inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non\u2010radiographic axial spondyloarthritis). Cochrane Database Syst Rev 7:CD010952. doi:10.1002\/14651858.CD010952","journal-title":"Cochrane Database Syst Rev"},{"key":"386_CR13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.33762\/mjbu.2009.49041","volume":"27","author":"K-AS Mahmood","year":"2009","unstructured":"Mahmood K-AS, Ahmed JH, Jawad AM (2009) Non-steroidal anti-inflammatory drugs (NSAIDs), free radicals and reactive oxygen species (ROS): a review of literature. Med J Basrah Univ 27:46\u201353","journal-title":"Med J Basrah Univ"},{"issue":"4","key":"386_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.semarthrit.2006.08.003","volume":"36","author":"M Mansour","year":"2007","unstructured":"Mansour M, Cheema GS, Naguwa SM, Greenspan A, Borchers AT, Keen CL, Gershwin ME (2007) Ankylosing spondylitis: a contemporary perspective on diagnosis and treatment. Semin Arthritis Rheum 36(4):210\u2013223","journal-title":"Semin Arthritis Rheum"},{"key":"386_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2741\/2692","volume":"13","author":"FO Martinez","year":"2007","unstructured":"Martinez FO, Sica A, Mantovani A, Locati M (2007) Macrophage activation and polarization. Front Biosci J Virtual Libr 13:453\u2013461","journal-title":"Front Biosci J Virtual Libr"},{"issue":"1","key":"386_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1073\/pnas.96.1.272","volume":"96","author":"BF McAdam","year":"1999","unstructured":"McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA (1999) Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 96(1):272\u2013277","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"386_CR17","first-page":"Pi105","volume":"10","author":"A Mirshafiey","year":"2004","unstructured":"Mirshafiey A, Khorramizadeh MR, Saadat F, Rehm BH (2004) Chemopreventive effect of M2000, a new anti-inflammatory agent. Med Sci Monit 10(10):Pi105\u2013Pi109","journal-title":"Med Sci Monit"},{"issue":"5","key":"386_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-3083.2005.01594.x","volume":"61","author":"A Mirshafiey","year":"2005","unstructured":"Mirshafiey A, Cuzzocrea S, Rehm B, Mazzon E, Saadat F, Sotoude M (2005a) Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug. Scand J Immunol 61(5):435\u2013441","journal-title":"Scand J Immunol"},{"issue":"8","key":"386_CR19","first-page":"Pi53","volume":"11","author":"A Mirshafiey","year":"2005","unstructured":"Mirshafiey A, Cuzzocrea S, Rehm BH, Matsuo H (2005b) M2000: a revolution in pharmacology. Med Sci Monit 11(8):Pi53\u2013Pi63","journal-title":"Med Sci Monit"},{"issue":"2","key":"386_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1081\/IPH-200067751","volume":"27","author":"A Mirshafiey","year":"2005","unstructured":"Mirshafiey A, Matsuo H, Nakane S, Rehm BH, Koh CS, Miyoshi S (2005c) Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis. Immunopharmacol Immunotoxicol 27(2):255\u2013265","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5","key":"386_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/1570180054405767","volume":"2","author":"A Mirshafiey","year":"2005","unstructured":"Mirshafiey A, Rehm B, Cuzzocrea S, Matsuo H, Mazzon E, Nakane S, Koh C-S, Miyoshi S (2005d) M2000, foundation of a new generation among NSAIDs. Lett Drug Des Discov 2(5):412\u2013423","journal-title":"Lett Drug Des Discov"},{"issue":"1","key":"386_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.etap.2007.02.002","volume":"24","author":"A Mirshafiey","year":"2007","unstructured":"Mirshafiey A, Rehm B, Abhari RS, Borzooy Z, Sotoude M, Razavi A (2007a) Production of M2000 (beta-d-mannuronic acid) and its therapeutic effect on experimental nephritis. Environ Toxicol Pharmacol 24(1):60\u201366","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"386_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/08923970701282387","volume":"29","author":"A Mirshafiey","year":"2007","unstructured":"Mirshafiey A, Rehm B, Sotoude M, Razavi A, Abhari RS, Borzooy Z (2007b) Therapeutic approach by a novel designed anti-inflammatory drug, M2000, in experimental immune complex glomerulonephritis. Immunopharmacol Immunotoxicol 29(1):49\u201361","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"386_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0090-6980(02)00029-1","volume":"68","author":"I Morita","year":"2002","unstructured":"Morita I (2002) Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat 68:165\u2013175","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"386_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/FJC.0b013e3182010a96","volume":"57","author":"MP Robich","year":"2011","unstructured":"Robich MP, Chu LM, Burgess TA, Feng J, Bianchi C, Sellke FW (2011) Effects of selective cyclooxygenase-2 and non-selective COX inhibition on myocardial function and perfusion. J Cardiovasc Pharmacol 57(1):122","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Supplement","key":"386_CR26","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","volume":"50","author":"CA Rouzer","year":"2009","unstructured":"Rouzer CA, Marnett LJ (2009) Cyclooxygenases: structural and functional insights. J Lipid Res 50(Supplement):S29\u2013S34","journal-title":"J Lipid Res"},{"issue":"31","key":"386_CR27","doi-asserted-by":"publisher","first-page":"28659","DOI":"10.1074\/jbc.M300671200","volume":"278","author":"H Samoto","year":"2003","unstructured":"Samoto H, Shimizu E, Matsuda-Honjyo Y, Saito R, Nakao S, Yamazaki M, Furuyama S, Sugiya H, Sodek J, Ogata Y (2003) Prostaglandin E2 stimulates bone sialoprotein (BSP) expression through cAMP and fibroblast growth factor 2 response elements in the proximal promoter of the rat BSP gene. J Biol Chem 278(31):28659\u201328667","journal-title":"J Biol Chem"},{"issue":"3","key":"386_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.berh.2010.01.005","volume":"24","author":"G Schett","year":"2010","unstructured":"Schett G, Rudwaleit M (2010) Can we stop progression of ankylosing spondylitis? Best Pract Res Clin Rheumatol 24(3):363\u2013371","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"386_CR29","first-page":"249","volume":"51","author":"SA Shaikh","year":"2007","unstructured":"Shaikh SA (2007) Ankylosing spondylitis: recent breakthroughs in diagnosis and treatment. J Can Chiropr Assoc 51(4):249\u2013260","journal-title":"J Can Chiropr Assoc"},{"issue":"Suppl 3","key":"386_CR30","doi-asserted-by":"publisher","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","volume":"61","author":"J Sieper","year":"2002","unstructured":"Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(Suppl 3):iii8\u2013iii18","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"386_CR31","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","volume":"284","author":"FE Silverstein","year":"2000","unstructured":"Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA 284(10):1247\u20131255","journal-title":"JAMA"},{"issue":"4","key":"386_CR32","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/art.23275","volume":"58","author":"I Song","year":"2008","unstructured":"Song I, Poddubnyy D, Rudwaleit M, Sieper J (2008) Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs. Arthritis Rheumatol 58(4):929\u2013938","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"386_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molimm.2013.06.017","volume":"57","author":"R Sorrentino","year":"2014","unstructured":"Sorrentino R, B\u00f6ckmann RA, Fiorillo MT (2014) HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity. Mol Immunol 57(1):22\u201327","journal-title":"Mol Immunol"},{"issue":"2","key":"386_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bpg.2009.11.005","volume":"24","author":"C Sostres","year":"2010","unstructured":"Sostres C, Gargallo CJ, Arroyo MT, Lanas A (2010) Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 24(2):121\u2013132","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"386_CR35","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/annrheumdis-2015-207677","volume":"75","author":"R Wang","year":"2016","unstructured":"Wang R, Dasgupta A, Ward MM (2016) Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials. Ann Rheum Dis 75(6):1152\u20131160","journal-title":"Ann Rheum Dis"},{"issue":"9\u201310","key":"386_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10354-010-0793-2","volume":"160","author":"J Wolf","year":"2010","unstructured":"Wolf J, Fasching P (2010) Ankylosing spondylitis. Wien Med Wochenschr 160(9\u201310):211\u2013214","journal-title":"Wien Med Wochenschr"},{"issue":"24","key":"386_CR37","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","volume":"340","author":"MM Wolfe","year":"1999","unstructured":"Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340(24):1888\u20131899","journal-title":"N Engl J Med"},{"issue":"7446","key":"386_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496(7446):445\u2013455","journal-title":"Nature"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-017-0386-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-017-0386-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-017-0386-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:33:20Z","timestamp":1628613200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-017-0386-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["386"],"URL":"https:\/\/doi.org\/10.1007\/s10787-017-0386-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"assertion":[{"value":"3 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}